|
Market Closed -
Sao Paulo
11:06:49 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 62.97 BRL | -0.90% |
|
-1.27% | -23.46% |
| 09-04 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 09-03 | Services Sector Growth Accelerates Amid Strong Demand, ISM, S&P Surveys Show | MT |
Company Valuation: S&P Global Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 113,676 | 109,123 | 139,557 | 154,372 | 158,240 | 130,735 | - | - |
| Change | - | -4% | 27.89% | 10.62% | 2.51% | -17.38% | - | - |
| Enterprise Value (EV) 1 | 111,285 | 118,792 | 149,725 | 164,104 | 169,583 | 144,027 | 143,180 | 142,072 |
| Change | - | 6.75% | 26.04% | 9.6% | 3.34% | -15.07% | -0.59% | -0.77% |
| P/E | 37.7x | 31.8x | 53.5x | 40.3x | 35.6x | 27.6x | 25.1x | 22.1x |
| PBR | 54x | 2.92x | 4.1x | 4.67x | 5.1x | 4.3x | 4.3x | 4.1x |
| PEG | - | -2x | -2.4x | 0.8x | 1.9x | 2.92x | 2.5x | 1.6x |
| Capitalization / Revenue | 13.7x | 9.21x | 11.2x | 10.9x | 10.3x | 8.93x | 8.37x | 7.82x |
| EV / Revenue | 13.4x | 10x | 12x | 11.6x | 11.1x | 9.84x | 9.16x | 8.49x |
| EV / EBITDA | 23.9x | 21.9x | 25.7x | 23.3x | 21.6x | 18.6x | 17.1x | 15.6x |
| EV / EBIT | 24.3x | 22.3x | 26.1x | 23.6x | 21.9x | 18.9x | 17.4x | 15.8x |
| EV / FCF | 33.4x | 30x | 36.9x | 28.8x | 30.9x | 26.4x | 23.7x | 21x |
| FCF Yield | 3% | 3.33% | 2.71% | 3.48% | 3.23% | 3.79% | 4.21% | 4.76% |
| Dividend per Share 2 | 3.08 | 3.32 | 3.6 | 3.64 | 3.84 | 3.922 | 4.094 | 4.441 |
| Rate of return | 0.65% | 0.99% | 0.82% | 0.73% | 0.73% | 0.88% | 0.92% | 1% |
| EPS 2 | 12.51 | 10.53 | 8.23 | 12.35 | 14.66 | 16.04 | 17.66 | 20.07 |
| Distribution rate | 24.6% | 31.5% | 43.7% | 29.5% | 26.2% | 24.4% | 23.2% | 22.1% |
| Net sales 1 | 8,297 | 11,842 | 12,497 | 14,208 | 15,336 | 14,633 | 15,627 | 16,725 |
| EBITDA 1 | 4,663 | 5,427 | 5,833 | 7,054 | 7,840 | 7,729 | 8,355 | 9,090 |
| EBIT 1 | 4,581 | 5,319 | 5,732 | 6,958 | 7,730 | 7,630 | 8,251 | 8,969 |
| Net income 1 | 3,024 | 3,543 | 2,626 | 3,852 | 4,471 | 4,766 | 5,021 | 5,701 |
| Net Debt 1 | -2,391 | 9,669 | 10,168 | 9,732 | 11,343 | 13,292 | 12,445 | 11,337 |
| Reference price 2 | 471.93 | 334.94 | 440.52 | 498.03 | 522.59 | 443.51 | 443.51 | 443.51 |
| Nbr of stocks (in thousands) | 240,875 | 325,800 | 316,800 | 309,966 | 302,800 | 294,774 | - | - |
| Announcement Date | 2/8/22 | 2/9/23 | 2/8/24 | 2/11/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.64x | 9.84x | 18.64x | 0.88% | 131B | |
| 26.09x | 5.91x | 14.83x | 2.43% | 45.79B | |
| 28.7x | 13.51x | 21.91x | 1.44% | 41.66B | |
| 26.54x | 3.8x | 12.01x | 1.27% | 20.8B | |
| 13.15x | 3.05x | 9.15x | 3.92% | 17.84B | |
| 20.98x | 4.93x | 12.33x | 3.16% | 16.6B | |
| 18.73x | 3.8x | 10.78x | 0.64% | 15.31B | |
| 20.04x | 4.8x | 12.85x | 1.49% | 10.74B | |
| 45.74x | - | - | 0.68% | 3.59B | |
| Average | 25.29x | 6.21x | 14.06x | 1.77% | 33.67B | |
| Weighted average by Cap. | 25.75x | 8.17x | 16.52x | 1.53% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SPGI Stock
- SPGI34 Stock
- Valuation S&P Global Inc.
Select your edition
All financial news and data tailored to specific country editions
